Evidence map›Paper›PMID 37298925›Full record

ReviewMolecules (Basel, Switzerland)2023

Towards the Application of Purely Inorganic Icosahedral Boron Clusters in Emerging Nanomedicine.

Francesc Teixidor, Rosario Núñez, Clara Viñas

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A NovelPharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Synthesis of new representatives of ABeilstein journal of organic chemistry · 2024
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francesc TeixidorInstitut de Ciència de Materials de Barcelona, ICMAB-CSIC, 08193 Bellaterra, Spain.
Rosario NúñezInstitut de Ciència de Materials de Barcelona, ICMAB-CSIC, 08193 Bellaterra, Spain.ORCID 0000-0003-4582-5148
Clara ViñasInstitut de Ciència de Materials de Barcelona, ICMAB-CSIC, 08193 Bellaterra, Spain.ORCID 0000-0001-5000-0277

Funding

Generalitat de Catalunya 2017SGR1720Spanish Ministerio de Economía y Competitividad PID2019-106832RB-I00
6 · The paper itself

Abstract

Traditionally, drugs were obtained by extraction from medicinal plants, but more recently also by organic synthesis. Today, medicinal chemistry continues to focus on organic compounds and the majority of commercially available drugs are organic molecules, which can incorporate nitrogen, oxygen, and halogens, as well as carbon and hydrogen. Aromatic organic compounds that play important roles in biochemistry find numerous applications ranging from drug delivery to nanotechnology or biomarkers. We achieved a major accomplishment by demonstrating experimentally/theoretically that boranes, carboranes, as well as metallabis(dicarbollides), exhibit global 3D aromaticity. Based on the stability-aromaticity relationship, as well as on the progress made in the synthesis of derivatized clusters, we have opened up new applications of boron icosahedral clusters as key components in the field of novel healthcare materials. In this brief review, we present the results obtained at the Laboratory of Inorganic Materials and Catalysis (LMI) of the Institut de Ciència de Materials de Barcelona (ICMAB-CSIC) with icosahedral boron clusters. These 3D geometric shape clusters, the semi-metallic nature of boron and the presence of

Indexed as

BoranesBoronHydrogenNanomedicinePharmaceutical PreparationsBoranesBoronHydrogenPharmaceutical PreparationsantimicrobialbioimagingBNCTcarboranesCOSANFESANluminescencemetallabis(dicarbollide)PBFRPETphotodinamic therapy (PDT)proton therapySPECT

Identifiers

PMID37298925
PMCPMC10254173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.